Home/Filings/4/0001617541-25-000005
4//SEC Filing

Dorton Katina 4

Accession 0001617541-25-000005

CIK 0001678660other

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 4:16 PM ET

Size

9.6 KB

Accession

0001617541-25-000005

Insider Transaction Report

Form 4
Period: 2025-10-17
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2025-10-17+76,00076,000 total
    Exercise: $1.19Exp: 2035-10-16Common Stock (76,000 underlying)
Footnotes (1)
  • [F1]The option award vests over a three year period equally one-thirty-sixth per month, subject to Reporting Person's continued service to the Company on each vesting date.

Issuer

Prelude Therapeutics Inc

CIK 0001678660

Entity typeother

Related Parties

1
  • filerCIK 0001617541

Filing Metadata

Form type
4
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 4:16 PM ET
Size
9.6 KB